Following the publication of ARDEnt’s ‘Making the Unseen Seen’ report, this is the webinar held on 11 May 2021 to explore and share the findings on the impact of COVID-19 on rare disease diagnosis, care, research, trials and drug development.
Nine recommendations were made to restore and improve services for the future.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalit...
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
